Emergency Contraception
16
1
2
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
44%
7 trials in Phase 3/4
45%
5 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (16)
Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel
Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
Quick Start of Highly Effective Contraception
Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
Continued Use of Effective Contraception After Use of Emergency Contraception
A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
Safety and Efficacy of CDB-2914 for Emergency Contraception
Depot Medroxyprogesterone Acetate as Emergency Contraception
Awareness & Use of Emergency Contraception
Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
Application for the Etonogestrel/Ethinyl Estradiol Ring
Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception
Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.
Emergency Contraception Actual Use Study
Medical Abortion for Emergency Contraception Failure
Efficacy Trial of CDB 2914 for Emergency Contraception